- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: cysteamine and cystic fibrosis.
Displaying page 1 of 1.
EudraCT Number: 2014-000284-40 | Sponsor Protocol Number: 3/001/14 | Start Date*: 2014-06-05 | |||||||||||
Sponsor Name:University of Aberdeen [...] | |||||||||||||
Full Title: An open label investigation of the tolerability and pharmacokinetics of oral cysteamine in adults with Cystic Fibrosis. | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001258-82 | Sponsor Protocol Number: CFTRcysta1 | Start Date*: 2013-09-12 |
Sponsor Name:European Institute for Cystic Fibrosis Research (IERFC) | ||
Full Title: A phase II pilot clinical study of experimental research to evaluate the functional rescue of CFTR protein through proteostasis regulators | ||
Medical condition: Cystic fibrosis patients with F508del-CFTR in homozygous or compound heterozygous with Class I or II mutations | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004986-99 | Sponsor Protocol Number: NBTCS02 | Start Date*: 2017-01-11 | |||||||||||
Sponsor Name:NovaBiotics, Ltd | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients with Cystic Fibrosis (C... | |||||||||||||
Medical condition: exacerbation of Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001259-29 | Sponsor Protocol Number: UoL001306 | Start Date*: 2019-03-12 | |||||||||||
Sponsor Name:University of LIverpool | |||||||||||||
Full Title: A PHASE 1B/2A STUDY TO ASSESS THE TOLERABILITY AND ADVERSE EFFECT PROFILE OF CYSTEAMINE (CYSTAGON) IN ADULTS AND CHILDREN WITH HOMOZYGOUS ΔF508 CYSTIC FIBROSIS, IN PATIENTS TAKING EPIGALLOCATECHIN-... | |||||||||||||
Medical condition: DeltaF508 Homozygous Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
